đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study aims to evaluate the safety, tolerability, efficacy and pharmaco...
Status
Recruiting
Location
The Second Affiliated Hospital of Dalian Medical University
Start Date
2026-03-27
Trial ID
NCT07389733
Treatments Being Tested
The study is being conducted to evaluate the efficacy and safety of HRS-808...
Status
Recruiting
Location
Chinese PLA General Hospital Fifth Medical Center
Start Date
2026-05-05
Trial ID
NCT07354022
Treatments Being Tested
The study is being conducted to evaluate the tolerance, and safety of HRS-8...
Status
Unknown
Location
Fifth Medical Center of People's Liberation Army of China General Hospital
Start Date
2022-02-17
Trial ID
NCT05189717
Treatments Being Tested
This is a multicenter, open phase Ib/II clinical study, which is divided in...
Status
Recruiting
Location
Chinese PLA General Hospital Fifth Medical Center
Start Date
2023-12-20
Trial ID
NCT06167694
Treatments Being Tested
This study is a multicenter, open-label, randomized controlled Phase 3 clin...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-07-23
Trial ID
NCT07024173
The study is being conducted to evaluate the relative bioavailability of HR...
Status
Completed
Location
The Frist Affiliated Hospital of USTC (Anhui Provincial Hospital)
Start Date
2024-10-10
Trial ID
NCT06619873
Treatments Being Tested
The study is being conducted to evaluate the efficacy and safety of HRS-808...
Status
Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2026-03-04
Trial ID
NCT07349069
This is a phase I study to evaluate the effect of Itraconazole on the pharm...
Status
Completed
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2025-11-26
Trial ID
NCT07229560
Treatments Being Tested